In order to further promote psoriasis slow disease management, the standard diagnosis and treatment of patients with psoriasis by psoriasis skin venereology branch of Chinese medical association professional committee and health services in anhui province association of psoriasis refers to southern China in 2020 action and GPA online training session for speaking, dandelion on October 9, 2020 in the third field optimal wheat successfully convened a doctor online platform.

        The meeting was hosted by Professor Sun Liang-Tan, director of the Key Laboratory of Dermatology of Anhui Medical University, Director of The Clinical Research Center of Anhui Dermatology and Director of the Psoriasis Research Center, and Professor Li Fu-qiu, director of the Dermatology department of the Second Hospital of Jilin University and chairman of the Dermatology branch of Jilin Province of Chinese Medical Doctors Association. , deputy director of the first hospital affiliated to China medical university dermatologist professor XiaoTing, qilu hospital of shandong university professor Sun Qing director of dermatology, the second hospital of jilin university, deputy director of dermatology and venereology skin jilin province branch of psoriasis, director of the committee members jian-xin xia, a professor at the Chinese medical association venereology branch psoriasis skin professional committee and the international psoriasis monitoring project (GPA) secretary zheng-wei zhu in China, the Chinese medical association, Dr Venereology skin psoriasis group members of the king of the second hospital of jilin university professor strong breeze, deputies to the national dermatologist fellow in a business and a total of more than 700 people attended the online meeting.

        Meeting presided over by Sun Liangdan professor and professor Li Fuqiu, first by the professor XiaoTing from psoriatic definition, epidemiology, pathogenesis, diagnosis and classification of the severity and the treatment of various aspects has carried on the detailed explanation, let everybody psoriasis guidelines of the 2018 edition of China had a deeper understanding, looking forward to the dermatologist under the guidance of guide to further standardize the diagnosis and treatment behavior.

        Sun Qing professor made the biological treatment of psoriasis expert consensus interpretation and application of psoriasis biological preparation principles and recommendations, biological treatment before the screening and treatment of monitoring, biological agents, and other treatment methods in the process of joint application, the curative effect of biological treatment of attenuation phenomenon and countermeasures, such as the application of special crowd biological agents for a detailed analysis.

        Jian-xin xia professor with "more accord with the demand of Chinese patients with psoriasis treatment", from the Chinese patients of skin quickly clear requirements, safety and efficacy lasting demand, joints and in the light of the demand of the refractory parts improve through detail IL17A crowd high expression in Asia, and a cornerstone role in the pathogenesis of psoriasis, combined with China's three phase of clinical trial data, confirmed the IL - 17 a inhibitor on the efficacy and safety of sophistication, treasurer, especially single drug is more suitable for the treatment of Chinese patients with psoriasis.

        Meeting in the first place in the second half of 2020 China psoriasis by Dr Zheng-wei zhu monitoring project (CGPA) is introduced, GPA is a long-term project, is for the purpose of continuous improvement on psoriasis cognition, and reveal its affect how individuals and the society as a whole, the first phase focused on in the prevalence of psoriasis and epidemic situation, future plans to add including diagnosis and treatment of psoriasis, complications work and improve patients' quality of life, economic burden, etc. The objective of CGPA is to understand the distribution, disease status, disease burden, economic burden and quality of life of psoriasis patients in China. The establishment of a psoriasis research cohort, long-term follow-up of patients, to improve the status of health care for psoriasis, reduce the burden on patients, improve the quality of life of patients, so as to provide information for China's research on the disease, policy and health care. At the present stage, GPA psoriasis patients are recruited to participate in psoriasis questionnaire nationwide based on GPA China monitoring site and psoriasis specialty clinic, and the epidemiological survey of GPA psoriasis patients is completed. Then Dr. Zhu Zhengwei explained the roles, steps and information input involved in the investigation system in an all-round way.

        In patients with "dandelion, popular science education", professor wang was in the psoriasis disease knowledge, in plain language, introduces in detail the definition of psoriasis and epidemiology, etiology, classification, clinical manifestations and severity, diagnosis and treatment of guidance in the actual clinical work better in psoriatic patients' education.

        The last part is the discussion. The professors and online doctors mainly focus on how to better implement GPA project and specific issues in the application of biological agents. Each professor answered all the questions according to the actual clinical work and related guidelines.

        At last, Professor Sun Liangdan and Professor Li Fuqiu made a summary of this meeting. It is believed that both dermatologists and friends of patients can benefit a lot from this presentation. Looking forward to the meeting, driven by the special committee of psoriasis, psoriasis ZhuanBing outpatient, psoriasis research center, and the joint efforts of China's GPA members units, able to provide China's global psoriasis epidemiology resource data, for the study of the disease all over the world, policy, and to provide information about health care, also let the results can benefit every psoriatic patients.

Writing | (jinxianhua, attending physician, dermatology department of the second hospital of jilin university)